|Professor Mark Walport|
|Born||Mark Jeremy Walport
25 January 1953 
Royal Brompton Hospital
Imperial College School of Medicine
University of Cambridge
Government of the United Kingdom
|Alma mater||Clare College, Cambridge|
|Thesis||The biology of complement receptors (1986)|
|Doctoral advisor||Peter Lachmann|
|Known for||Director of Wellcome Trust (2003-2013)
Government Chief Scientific Adviser (2013-date)
|Notable awards||Roche Rheumatology Prize (1991)
Graham Bull Prize in Clinical Science (1996)
Fellow of the Academy of Medical Sciences (1998)
Knight Bachelor (2009)
Fellow of the Royal Society (2011)
|Spouse||Julia Elizabeth Neild|
Walport is the son of a general practitioner and was born in London. He was educated at St Paul's School, London, studied medicine at the University of Cambridge (Clare College) and completed his clinical training at Hammersmith, Guy's and Brompton Hospitals in London. He was awarded a PhD for research into complement receptors under the supervision of Peter Lachmann in 1986 at the University of Cambridge.
Previously Walport was Director of the Wellcome Trust from 2003 to 2013. Before this, he was Professor of Medicine (from 1991) and Head of the Division of Medicine (from 1997) at Imperial College London, where he led a research team that focused on the immunology and genetics of rheumatic diseases.
At the beginning of his tenure as Chief Science advisor to the UK, one of his first acts was to champion neonicotinoids shortly before a vote in the European Parliament on a partial ban. In defending the pesticide on the grounds that using older pesticides could be more expensive and damaging to wildlife, he cited a DEFRA-commissioned study which had not been peer-reviewed, which purported to show that neonicotinoids do not harm bees. The study was later criticized by the European Food Safety Authority. Walport's article was criticised in The Guardian for misinforming the public, for making "groundless, unscientific and emotionally manipulative claims", and for misunderstanding the precautionary principle.
- "WALPORT, Sir Mark (Jeremy)" (Who's Who 2013, A & C Black, an imprint of Bloomsbury Publishing plc, 2013; online edn, Oxford University Press).(subscription required)
- Reed, Tanya (11 July 2003). "Wellcome to a new beginning". Reporter: The newspaper of Imperial College London (131).
- Vogel, G. (2003). "United Kingdom: Mark Walport to Take Reins at Wellcome Trust". Science 299 (5608): 803a–. doi:10.1126/science.299.5608.803a. PMID 12574591.
- Callaway, E. (2012). "Britain names next chief science adviser: Immunologist Mark Walport, head of one of the world’s largest biomedical charities, will take on role in 2013.". Nature 487 (7405): 20. doi:10.1038/487020a.
- "Sir Mark Walport FRS | Royal Society". Retrieved 2012-07-05.
- "Dr Sir Mark Walport". Debrett's People of Today. Retrieved 14 February 2012.
- Mayor, S. (2012). "Mark Walport will be next UK government chief scientific adviser, cabinet office announces". BMJ 345: e4621. doi:10.1136/bmj.e4621. PMID 22767620.
- Kain, K. H. (2010). "Funding scientific discovery: An interview with Sir Mark Walport". Disease Models & Mechanisms 3 (5–6): 265–267. doi:10.1242/dmm.005710. PMID 20427555.
- Anon (2012). "Good advice: The UK government's latest appointment offers hope for British science.". Nature 487 (7405): 5. doi:10.1038/487005b.
- Gibney, Elizabeth (29 June 2012). "New chief scientific adviser announced". Times Higher Education.
- Morris, K. (2003). "Mark Walport". The Lancet 362 (9382): 498–499. doi:10.1016/S0140-6736(03)14090-1.
- Walport, Mark Jeremy (1986). The biology of complement receptors (PhD thesis). University of Cambridge.
- "Mark Walport, Ph.D.,MB. BChir. , Member, Scientific Board". Grand Challenges in Global Health. Retrieved 14 February 2012.
- Walport, M.; Foulkes, I.; Weissberg, P.; Morgan, D.; Nebhrajani, S. (2012). "Medical research: No catch to UK charity funding". Nature 482 (7385): 308. doi:10.1038/482308a. PMID 22337042.
- Collins, P. Y.; Patel, V.; Joestl, S. S.; March, D.; Insel, T. R.; Daar, A. S.; Scientific Advisory Board the Executive Committee of the Grand Challenges on Global Mental Health; Bordin, I. A.; Anderson, E. J.; Dhansay, M.; Phillips, C.; Shurin, R. I.; Walport, W.; Ewart, Y.; Savill, S. E.; Bordin, K.; Costello, S.; Durkin, S.; Fairburn, A.; Glass, A.; Hall, A.; Huang, M. M.; Hyman, V.; Jamison, B. J.; Kaaya, S.; Kapur, P. A.; Kleinman, D. J.; Ogunniyi, W.; Otero-Ojeda, M. A.; Poo, W.; Ravindranath, A. (2011). "Grand challenges in global mental health". Nature 475 (7354): 27–30. doi:10.1038/475027a. PMC 3173804. PMID 21734685.
- Yamada, T.; Dautry, A.; Walport, M. (2008). "Ready for avian flu?". Nature 454 (7201): 162. doi:10.1038/454162a. PMID 18615064.
- Pickering, M. C.; Warren, J.; Rose, K. L.; Carlucci, F.; Wang, Y.; Walport, M. J.; Cook, H. T.; Botto, M. (2006). "Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice". Proceedings of the National Academy of Sciences 103 (25): 9649–9654. doi:10.1073/pnas.0601094103. PMC 1476693. PMID 16769899.
- Brown, J. S.; Hussell, T.; Gilliland, S. M.; Holden, D. W.; Paton, J. C.; Ehrenstein, M. R.; Walport, M. J.; Botto, M. (2002). "The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice". Proceedings of the National Academy of Sciences 99 (26): 16969–16974. doi:10.1073/pnas.012669199. PMC 139253. PMID 12477926.
- Botto, M.; Fong, K. Y.; So, A. K.; Barlow, R.; Routier, R.; Morley, B. J.; Walport, M. J. (1992). "Homozygous hereditary C3 deficiency due to a partial gene deletion". Proceedings of the National Academy of Sciences of the United States of America 89 (11): 4957–4961. doi:10.1073/pnas.89.11.4957. PMC 49207. PMID 1350678.
- Taylor, P. R.; Carugati, A.; Fadok, V. A.; Cook, H. T.; Andrews, M.; Carroll, M. C.; Savill, J. S.; Henson, P. M.; Botto, M.; Walport, M. J. (2000). "A Hierarchical Role for Classical Pathway Complement Proteins in the Clearance of Apoptotic Cells in Vivo". Journal of Experimental Medicine 192 (3): 359–366. doi:10.1084/jem.192.3.359. PMC 2193213. PMID 10934224.
- "Government refuses to support ban on neonicotinoids despite protests". The Daily Telegraph. Retrieved 4 October 2013.
Sir John Beddington
|Government Chief Scientific Adviser
|Director of Wellcome Trust